Niu Lizhi

Neu
30 Jahre der Erfahrung
Akkredititationen:
Standort: China, Kanton
Klinik:
4.6
Fuda Cancer Hospital
Nahezu 10.000 durchgeführte Kryochirurgien – Prof. Niu Lizhi leitet das Programm für minimalinvasive Onkologie am Fuda Cancer Hospital.
- Über 20 Jahre amtierender Präsident und Chefchirurg am Fuda Cancer Hospital
- Pionier in Kryochirurgie und NanoKnife-Verfahren zur Krebsbehandlung
- Vizepräsident sowohl der asiatischen als auch der internationalen Gesellschaft für Kryochirurgie
- Autor von über 100 Forschungsarbeiten zu chirurgisch-onkologischen Techniken
- Betreuer an der Jinan-Universität, Ausbildung künftiger Onkologen
Mehr lesen

Neu

Arztbesuch

Preis auf Anfrage

Liuying

Neu
20 Jahre der Erfahrung
Standort: China, Kanton
Klinik:Jinshazhou-Krankenhaus der Universität für Chinesische Medizin Guangzhou
Dr. Liuying leitet die Onkologieabteilung des Jinshazhou Hospital der Guangzhou University of Chinese Medicine. Klinische Schwerpunkte sind hepatozelluläres Karzinom, Cholangiokarzinom sowie Lungen- und kolorektale Karzinome. Dr. Liuying verfügt über besondere Expertise bei Melanom und Melanom-Lebermetastasen. Interventionelle Verfahren umfassen MWA (Mikrowellenablation), RFA (Radiofrequenzablation), Kryoablation und die Implantation radioaktiver Seeds zur nichtvaskulären, minimalinvasiven Tumorablation.

Forschung: Teilnahme an zwei Wissenschafts- und Technologieprojekten der Provinz Guangdong. Mitwirkung am Expertenkonsens 2014 zur thermischen Ablation primärer und metastatischer Lungentumoren. Publikation im Chinese Journal of Lung Cancer. Zusammenstellung der Fallreihen Ausgewählte Fälle der Mikrowellenablation bei Lungentumoren und Ausgewählte Fälle der Mikrowellenablation bei Lebertumoren.

Ämter: Mitglied des Ständigen Ausschusses des Jugendausschusses für intratumorale Brachytherapie der China Medical Education Association. Mitglied des Ständigen Ausschusses des Fachkomitees für minimalinvasive interventionelle Medizin der Guangdong Primary Medical Association.
Mehr lesen

Neu

Paketpreis ab$7,000

Lo Zhunchen

Neu
Standort: China, Kanton
Klinik:
4.6
Fuda Cancer Hospital
Dr. Lo Zhunchen verfügt über mehr als 20 Jahre Erfahrung in der Pneumologie und klinischen Hämatologie am Fuda Cancer Hospital.
- Auf Innere Medizin, Pneumologie und klinische Hämatologie spezialisieren
- In Chemo- und Strahlentherapiebehandlungen erfahren sein
- Sich auf Patientenkomfort und -zufriedenheit konzentrieren
- Sich der evidenzbasierten Medizin und Patientenaufklärung verpflichten
Mehr lesen

Neu

Arztbesuch

Preis auf Anfrage

Erkenntnisse von Bookimed: Top-Spezialisten für Lungenkrebs in China ()

Bookimed hat 1 Anfragen für die Behandlung von Lungenkrebs in China koordiniert und arbeitet mit 3 Top-Spezialisten zusammen. Die Ärzte in dieser Tabelle werden basierend auf internationalen Qualifikationen, klinischer Expertise und Patientenergebnissen ausgewählt. Das Ranking für basiert auf verifizierten Daten aus echten Patientenfällen und aktuellen Programmen unserer Partnerkliniken.

Rang	Arzt	Erfahrung	Gut geeignet für	Was sie einzigartig macht	Klinik & Standort	Beratung
#1	Niu Lizhi	30 Jahre der Erfahrung	Minimalinvasive Lungenkrebsbehandlung	Führender Experte für Kryochirurgie mit internationaler Anerkennung – Vizepräsident von Fachgesellschaften für Kryochirurgie. Er wendet zusammen mit seinem Team modernste Techniken wie das NanoKnife an.	Fuda Cancer Hospital China	Preis auf Anfrage
#2	Lo Zhunchen		Atemwegs- und hämatologische Fälle	Spezialisiert auf Beatmungsmedizin und klinische Hämatologie mit umfassender Erfahrung in Chemo- und Radiotherapie. Schwerpunkt auf Patientenkomfort und evidenzbasierter Pflege.	Fuda Cancer Hospital China	Preis auf Anfrage

FAQ

Diese FAQs stammen von echten Patienten, die über Bookimed medizinische Hilfe suchen. Die Antworten werden von erfahrenen medizinischen Koordinatoren und vertrauenswürdigen Klinikvertretern gegeben.

Is lung cancer treatment in China of high quality for international patients?

China provides high-quality lung cancer care through specialized oncology centers in Guangzhou, Shanghai, and Beijing. These JCI-accredited facilities offer advanced technologies like CyberKnife M6 and NanoKnife. High patient volumes allow surgeons to achieve remarkable procedural mastery in minimally invasive thoracic surgeries.

Advanced technology: Facilities use CyberKnife M6 and proton-beam therapy for tumors.
Specialized therapies: Clinics offer NanoKnife, cryosurgery, and vascular interventional therapy.
Surgical expertise: Dr. Niu Lizhi has performed nearly 10,000 successful cryosurgery procedures.
Rapid diagnostics: Centers combine PET-CT, genomic sequencing, and tumor markers for staging.

Bookimed Expert Insight: High-volume centers like Fuda Cancer Hospital treat 30,000+ international patients yearly. This massive data pool helps specialists refine protocols for advanced stages. Dr. Liuying at Jinshazhou Hospital even contributed to national expert consensus on lung tumor ablation. This level of specialization ensures that doctors see more complex cases in one month than many Western surgeons see in a year.

Patient Consensus: Patients note that top-tier care often rivals Western standards, especially for targeted therapies. They recommend hiring a private Mandarin translator and utilizing VIP departments to navigate language barriers effectively.

What advanced lung-cancer therapies are available in China?

Advanced lung cancer therapies in China center on next-generation immunotherapy and high-precision minimally invasive procedures. Facilities utilize domestic breakthroughs like Ivonescimab alongside international standards. Molecularly targeted drugs for EGFR and ALK mutations are widely available. Treatment often integrates CyberKnife M6 radiosurgery and specialized cryosurgical ablation.

Targeted therapy: Broad access to domestic TKIs like Aumolertinib and Furmonertinib for EGFR mutations.
Immunotherapy: Novel monoclonal antibodies including Camrelizumab and Tislelizumab are standard first-line options.
Minimally invasive: Facilities provide cryosurgery, NanoKnife ablation, and radiofrequency ablation for localized tumor control.
Advanced radiation: CyberKnife M6 systems deliver precise radiosurgery for complex cases in oncology centers.

Bookimed Expert Insight: A major advantage for lung cancer patients in China is the massive scale of specialized centers. Dr. Niu Lizhi at Fuda Cancer Hospital has performed over 10,000 cryosurgeries. This high volume often translates to expertise in treating late-stage cancers. Patients can access specific technologies like NanoKnife that are less common in standard European or North American protocols.

Patient Consensus: Patients value the speed of enrollment for clinical trials and the affordability of genomic testing. Many suggest using official hospital mobile apps for scheduling to streamline care during their stay.

Which hospitals are internationally recommended for lung-cancer treatment in China?

Top-tier Chinese hospitals for lung cancer treatment include JCI-accredited centers like Fuda Cancer Hospital and the Cancer Hospital of the Chinese Academy of Medical Sciences. These institutions offer advanced therapies such as cryosurgery, NanoKnife, and CyberKnife M6. They follow international NCCN guidelines while processing high patient volumes.

Fuda Cancer Hospital: JCI-accredited facility in Guangzhou specializing in minimally invasive treatments for advanced stage cases.
Jinshazhou Hospital: Offers CyberKnife M6 stereotactic radiosurgery and standardized microwave ablation for targeted tumor destruction.
Specialized surgical volumes: National centers in Beijing and Shanghai perform thousands of thoracic surgeries annually.
International patient services: Selected hospitals provide dedicated translation and coordinators for over 100 countries.

Bookimed Expert Insight: While high-profile national centers in Beijing handle massive volumes, private JCI-accredited hospitals like Fuda Cancer Hospital offer a significant coordination advantage. Dr. Niu Lizhi at Fuda has performed nearly 10,000 cryosurgeries. This specific procedural experience often exceeds that of western specialists. Choosing a clinic with such high individual doctor case numbers can lead to better precision in complex, minimally invasive lung procedures.

Patient Consensus: Patients note that while medical technology is advanced, having a professional coordinator is vital for navigating language barriers. Many emphasize that the high surgical volume translates to very experienced thoracic teams and modern immunotherapy options.

How do international patients overcome language barriers and manage logistics?

International patients manage lung cancer treatment in China through dedicated international departments providing on-site interpreters and logistical support. Facilities like Fuda Cancer Hospital serve over 30,000 global patients. Specialized coordinators handle medical visa invitations, airport transfers, and local housing to ensure seamless clinical transitions.

Professional interpretation: Experts handle nuanced discussions for therapies like NanoKnife or CyberKnife M6.
Coordinated logistics: International desks arrange travel, visa extensions, and halal or kosher meals.
Bundled packages: Packages often include consultations, medications, transfers, and hospitalization for streamlined care.
Digital support: Clinics provide SIM cards with translation apps and WeChat group communication.

Bookimed Expert Insight: While many think Tier-1 cities are the only option, Guangzhou has emerged as a specialized hub for lung cancer. Fuda Cancer Hospital and Jinshazhou Hospital offer advanced technologies like Cryosurgery and CyberKnife M6. These centers prioritize international patients, with surgeons like Dr. Niu Lizhi having performed nearly 10,000 cryosurgeries.

Patient Consensus: Patients emphasize that hiring a private medical interpreter is essential for accurate dosing. They also suggest joining digital expat networks to navigate mobile payments and high-speed rail travel successfully.

Can I secure a remote second opinion before traveling to China?

International patients can secure remote second opinions for lung cancer treatment in China through virtual consultations or written reports. Leading facilities in Guangzhou and Shanghai use telemedicine to review pathology slides and CT scans. This process establishes treatment protocols and provides cost clarity before patients commit to international travel.

Consultation methods: Patients access specialists via video calls, text-based reviews, or formal written reports.
Required documentation: Experts require digital pathology reports, CT/MRI imaging, and biomarker testing results (EGFR/ALK).
Turnaround time: Most international departments deliver a formal specialist opinion within 7 to 14 days.
Advanced technologies: Reviews may include suitability for CyberKnife M6, NanoKnife, or cryosurgery for late-stage cases.

Bookimed Expert Insight: Bookimed data shows that packages for advanced therapies, such as the CyberKnife M6 at Jinshazhou Hospital, often include the initial video or text consultation as a standard service. This allows patients to confirm the technical feasibility of stereotactic radiosurgery before arrival. Dr. Zhang Yanjun and other specialists at this facility integrate these remote screenings to ensure the 56,000 CNY treatment cost is medically justified for the specific tumor stage.

Patient Consensus: Patients emphasize that sharing digital pathology slides is essential for accurate remote reviews. Many note that high-volume centers like Fuda Cancer Hospital provide preliminary assessments via digital channels to help clarify complex cases early.

Beste Lungenkrebs Ärzte in Kanton - TOP -3 Ärzte

Erhalten Sie Angebote von 3 Top-Spezialisten für in China